Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01280916 · ClinicalTrials.gov registry record · Phase 1

Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment

A Phase 1 study of Substance Use Disorder, sponsored by University of Washington.

Completed
Registry status
Phase 1
Development phase
46
Enrollment target
1
Study location

NCT01280916 is a Phase 1 study of Substance Use Disorder that has completed, run by University of Washington. The registered enrollment target is 46 participants, below the 819-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01280916, a Phase 1 study of Substance Use Disorder, has completed, sponsored by University of Washington.

COMPLETED
Registry status
Phase 1
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this exploratory and developmental study is to evaluate a mind-body intervention for relapse prevention for women in addiction treatment. The proposed intervention, Mindful Awareness in Body-Oriented Therapy (MABT), is a novel mind-body intervention designed to enhance embodiment and to facilitate mindfulness through the combination of massage, body awareness exercises and the acquisition of mindfulness skills. The treatment goals of MABT include reduction of avoidant coping responses, increase of emotional-regulation, and decrease of trauma symptoms through access to and acceptance (vs. avoidance) of sensory and emotional experience. These are thought to be important for relapse prevention given the positive association between stress, negative affect and relapse; and risk of relapse associated with PTSD symptoms. Mind-body interventions in relapse prevention are of increased clinical and scientific interest, particularly for the potential to overcome automatic response patterns that are associated with lapse and relapse in substance use treatment. This proposal falls within the current NIDA research portfolio focus on the development of interventions that will help people better cope with stress, negative affect, and trauma. Specific Aims: * Aim 1: To examine feasibility of recruitment to and retention in MABT as an adjunct to substance abuse treatment. Specifically, to describe a) study enrollment and barriers to recruitment, b) sample characteristics, c) response to randomization, d) session attendance, and e) loss to follow-up. * Aim 2: To describe MABT acceptability to study participants and substance abuse treatment staff. * Aim 3: To compare the effect of body-oriented therapy plus treatment-as-usual vs. treatment-as-usual only on reported days abstinent for overall substance use and primary drug use among women receiving substance abuse treatment, in order to estimate the effect size. Secondary analyses will examine for intervention

Conditions Studied

Interventions

  • BEHAVIORAL Mindful Awareness in Body-oriented Therapy

Study Locations (1)

Washington

  • Residence XII - Kirkland

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 2008-10
Est. Completion 2011-03
Phase Phase 1

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01280916

The ClinicalTrials.gov registry entry for NCT01280916 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 18 other Substance Use Disorder trials with a reported enrollment target (94% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Substance Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Mindful Awareness in Body-oriented Therapy is the first listed.

NCT01280916 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT01280916 about?

NCT01280916 is a clinical study titled "Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment". The primary purpose of this exploratory and developmental study is to evaluate a mind-body intervention for relapse prevention for women in addiction treatment. The proposed intervention, Mindful Awareness in Body-Oriented Therapy (MABT), is a novel mind-body intervention designed to enhance embodim...

What is the current status of trial NCT01280916?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 46 participants. The study started on 2008-10. Estimated completion is 2011-03.

What conditions does trial NCT01280916 study?

This clinical trial studies the following conditions: Substance Use Disorder.

What interventions are being tested in trial NCT01280916?

The interventions under investigation include: Mindful Awareness in Body-oriented Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01280916?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01280916 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.